The Australian Institute for Bioengineering and Nanotechnology has hosted British monoclonal antibody pioneer Sir Greg Winter for a lab tour as part of a strategic collaboration with biotechnology company Biosceptre International.
4 April 2012The Australian Institute for Bioengineering and Nanotechnology has hosted British monoclonal antibody pioneer Sir Greg Winter for a lab tour as part of a strategic collaboration with biotechnology company Biosceptre International.
4 April 2012